503 Patents
| S.No | Title | Patent No | Brand /Ingredient |
|---|---|---|---|
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | India IN514647 | Oletrip | |
| Skin care compositions and their applications | India IN356811 | Ethyl Asccorbic acid + SabiWhite® | |
| A method for solubilizing forskolin and a composition thereof | India IN235492 | Ocufors® | |
| A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition | India IN238950 | Boswellin® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | India IN484255 | Arjuna | |
| A process for obtaining high purity fatty alcohols | India IN229695 | Policosanol |
- Australia 45
- Brasil 2
- Canada 43
- China 13
- DPR Korea 1
- Eurasia 20
- Europe 37
- Germany 1
- Great Britain 1
- Hong Kong 11
- Indonesia 14
- Japan 49
- Malaysia 12
- Mexico 7
- New Zealand 29
- Philippines 12
- Republic of Korea 29
- Russia 12
- Singapore 13
- South Africa 15
- Taiwan 2
- UAE 2
- USA 120
- Uzbekistan 1
- Vietnam 2
| S.No | Title | Patent No | Brand /Ingredient |
|---|---|---|---|
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | Australia AU2018282020 | LactoSporin® | |
| Modulation of immune function by Bacillus coagulans | Australia AU2019262918 | Immunospore | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | Australia AU2019449279 | Hypertension formulation | |
| Fructophilic lactic acid producing bacteria | Australia AU2019445706 | Fructospore | |
| Aphrodisiac composition and management of male sexual dysfunction | Australia AU2019430124 | Withanalpha® | |
| Adaptogenic compositions and applications thereof | Australia AU2016393811 | Boswellin® PS + Saberry®/Cococin® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Australia AU2016358297 | LactoSpore® | |
| Composition containing Oroxylin A and method of extraction thereof | Australia AU2017356883 | Sabroxy® | |
| Skin care compositions and their applications | Australia AU2019249392 | Ethyl ascorbic acid + THC | |
| Liver protectant composition and therapeutic applications | Australia AU2019240210 | LivLonga® | |
| Compositions for the management of hyperglycemia and related conditions | Australia AU2018397668 | Nigellin® | |
| Spent turmeric- methods and compositions thereof | Australia AU2018307222 | Starmeric® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Australia AU2018290219 | Arjuna | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Australia AU2018282067 | LactoSporin® | |
| Compositions for management of Helicobacter pylori infections | Australia AU2018281141 | LactoSpore® + Saberry® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Australia AU2006235807 | Curcumin C3 Reduct | |
| Compositions containing thymohydroquinone and their method of preparation | Australia AU2018397667 | Nigellin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Australia AU2018337853 | LactoSpore® | |
| Compositions and methods for reducing flatulence | Australia AU2018282018 | LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Australia AU2018282252 | LactoSporin® | |
| Enzyme composition for therapeutic management of muscle soreness | Australia AU2016428484 | DigeZyme® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Australia AU2016413572 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2015394033 | Cyperus | |
| Oleanoyl peptide compositions and collagen enhancement | Australia AU2015381703 | Olepent® | |
| Bioavailable composition of natural and synthetic HCA | Australia AU773081 | Garcitrin® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Australia AU2004322710 | Boswellin® | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Australia AU2006321973 | SelenoForce® | |
| Process for preparing water soluble diterpenes and their applications | Australia AU2004272005 | Ocufors® | |
| Anti-obesity potential of Calebin A | Australia AU2012366253 | CurCousin® | |
| Hepatoprotectant activity of garcinol | Australia AU2011352073 | Livinol™ | |
| Composition for down-regulating pro-inflammatory markers | Australia AU2011200854 | Boswellin® PS | |
| Protective compositions for dermal papilla cells | Australia AU2010326651 | Saberry® + Cococin | |
| Oleanoyl peptide composition and a method of treating skin aging | Australia AU2011265587 | Olepent® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2014369819 | LactoSporin® | |
| Method for the treatment of hypercholesterolemia | Australia AU2014202312 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Australia AU2012203148 | Saberry® + Cococin+ Se Peptide | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Australia AU2015308650 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2013292593 | Cyperus | |
| Composition and method for the protection of articular cartilage | Australia AU2014201769 | CurCousin® | |
| Anti-obesity potential of Calebin A | Australia AU2014203122 | CurCousin® | |
| Process and compositions for achieving mammalian energy balance | Australia AU2015351423 | Forskolin | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | Australia AU2016385393 | Zingiber cassumnar | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Australia AU2018335280 | LactoSporin® | |
| Synthesis of Calebin A and its biologically active analogs | Australia AU2014203764 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2017228561 | LactoSporin® | |
| Compositions containing thymohydroquinone and their method of preparation | Brasil BR 11 2020 012333-1 | Nigellin® | |
| Aphrodisiac composition and management of male sexual dysfunction | Brasil BR 11 2020 025686-2 | WithanAlpha™ | |
| Skin care compositions and their applications | Brasil BR 11 2020 020445-5 | Ethyl Ascorbic Acid + SabiWhite® | |
| Curcuminoid composition and its therapuetic potential in managing lung fibrosis | Canada CA3153877 | C3 Reduct® Special | |
| Plant actives and their anti-pollution effects thereof | Canada CA3152792 | Sabroxy® + (THC / Pterostilbene / Artonox) | |
| Liver protectant composition and therapeutic applications | Canada CA3094625 | LivLonga® | |
| Compositions for microbial anti-adhesion | Canada CA3083777 | LactoCran™ | |
| Hypolipidemic effects of Bacillus coagulans | Canada CA3065162 | LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Canada CA3087050 | Nigellin® | |
| Compositions for the management of hyperglycemia and related conditions | Canada CA3087042 | Nigellin® | |
| Process for the preparation of standardized composition of from the bark of Terminalia arjuna | Canada CA3066772 | Arjuna | |
| Neuroprotective compositions and their use | Canada CA3063757 | Sabroxy® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Canada CA3075635 | Oletrip | |
| Compositions for management of Helicobacter pylori infections | Canada CA3061613 | LactoSpore® + Saberry® | |
| Spent turmeric - Methods and compositions thereof | Canada CA3071190 | Starmeric® | |
| Compositions for reducing trimethylamine-n-oxide and related therapeutic applications | Canada CA3076739 | Pterostilbene | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Canada CA3065334 | LactoSporin® | |
| Composition and methods for beta secretase inhibition | Canada CA3063751 | Sabroxy® | |
| Alcoholic beverage composition containing Bacillus coagulans | Canada CA3075642 | LactoSpore® | |
| Anti-pollution compositions containing Bacillus coagulans | Canada CA3074267 | LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Canada CA3064939 | LactoSporin® | |
| Adaptogenic compositions and applications thereof | Canada CA3014238 | Boswellin® PS + Saberry® / Cococin® | |
| Use of piperine as a bioavailability enhancer | Canada CA2247467 | BioPerine® | |
| Forskolin for promoting lean body mass | Canada CA2281562 | ForsLean® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Canada CA3047702 | Artocarpus hirsutus | |
| Composition containing Oroxylin A and method of extraction thereof | Canada CA3043168 | Sabroxy® | |
| Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Canada CA3047701 | Artocarpus hirsutus | |
| Bacillus coagulans MTCC 5856 For The Management Of Major Depressive Disorder | Canada CA3023818 | LactoSpore® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Canada CA2999517 | LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Canada CA2967952 | LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Canada CA2883176 | Cyperus | |
| Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins | Canada CA2537820 | Ocufors® | |
| Anti-obesity Potential of Calebin A | Canada CA2857543 | CurCousin® | |
| Composition for down-regulating pro-inflammatory markers | Canada CA2732915 | Boswellin® PS | |
| Hepatoprotectant activity of garcinol | Canada CA2851663 | Livinol | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Canada CA2872535 | Saberry® + Cococin+ Se Peptide | |
| Method for the treatment of hypercholesterolemia | Canada CA2850999 | CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | Canada CA2858126 | CurCousin® | |
| Calebin A for hepatic steatosis | Canada CA2893321 | CurCousin® | |
| Composition and method for the protection of articular cartilage | Canada CA2935898 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Canada CA2899511 | LactoSporin®, LactoSporin® + SabiLize® | |
| Method for the treatment of hypercholesterolemia | Canada CA2963383 | CurCousin® | |
| Calebin A for osteoporosis | Canada CA2941050 | CurCousin® | |
| Oleanoyl peptide composition and collagen enhancement | Canada CA2975170 | Olepent® | |
| Method to solubilize curcuminoids in water | Canada CA2976689 | uC3 CLEAR | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Canada CA2979287 | Zingiber cassumnar | |
| Method for the treatment of hypercholesterolemia | Taiwan I622384 | CurCousin® | |
| Composition for down-regulating pro-inflammatory markers | Taiwan I-434696 | Boswellin® PS | |
| Method of enhancing the viable counts of lactic acid bacteria and method of producing short chain fatty acids | Vietnam VN33287 | LactoSpore® | |
| Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same | Vietnam 12717 | Ocufors® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Germany DE10196213 | Cosmoperine® | |
| Liver protectant compositions and therapeutic applications | Hong kong HK40045252 | LivLonga® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Hong kong HK1240122 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Hong kong HK1232483 | Cyperus | |
| Process and compositions for achieving mammalian energy balance | Hong kong HK1238675 | Forskolin | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Hong kong HK1233174 | LactoSpore® | |
| Synthesis of Calebin A and its biologically active analogs | Hong kong HK1217689 | CurCousin® | |
| Process for preparing water soluble diterpenes and their applications | Hong kong HK1098450 | Ocufors® | |
| Method for the treatment of hypercholesterolemia | Hong kong HK1210590 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Hong kong HK1193758 | Saberry®+ Cococin + Se Peptide | |
| Calebin A for articular cartilage | Hong kong HK1210028 | CurCousin® | |
| Calebin A for use in the treatment of Inflammation and obesity | Hong kong HK1190874 | CurCousin® | |
| Compositions for managing chronic obstructive pulmonary disease | China ZL 202180015345.2 | Curucmin BD3 Complex | |
| Plant actives and their anti-pollution effects thereof | China ZL202080072290.4 | Sabroxy® + (THC / Pterostilbene / Resvenox®) | |
| Enzyme composition for therapeutic management of muscle soreness | China ZL201680090576.9 | DigeZyme® | |
| Compositions for the management of hyperglycemia and related conditions | China ZL201880083854.7 | Nigellin® | |
| Compositions containing thymohydroquinone and their method of preparation | China ZL201880083853.2 | Nigellin® | |
| Composition containing Oroxylin A and method of extraction thereof | China ZL201780070049.6 | Sabroxy® | |
| Process and compositions for achieving mammalian energy balance | China ZL201580083933.4 | Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | China ZL201680008035.7 | LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | China ZL201580042813.X | LactoSpore® | |
| Process For Preparing Water Soluble Diterpenes And Their Applications | China ZL200480028804.7 | Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | China ZL200480043675.9 | Boswellin® | |
| Anti-obesity potential of Calebin A | China ZL201280012577.3 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | China ZL201480010615.0 | LactoSporin®, LactoSporin® + SabiLize® | |
| Melanogenesis inhibition by 3,5-dimethoxy-4'-hydroxypterostilbenes and cosmeceutical applications thereof | DPR Korea 1011504 | pTeroWhite | |
| Composition containing Oroxylin A and method of extraction thereof | Europe EP3538089 | Oroxylin | |
| Composition and methods for beta secretase inhibition | Europe EP3638277 | Sabroxy® | |
| Alcoholic beverage composition containing Bacillus coagulans | Europe EP3684900 | LactoSpore® | |
| Liver protectant compositions and therapeutic applications | Europe EP3768237 | LivLonga® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Europe EP3634375 | LactoSporin® | |
| Natural molecules from Artocarpus hirsutus: method of isolation and anti-acne potential thereof | Europe EP3558958 | Artocarpus | |
| Compositions for management of Helicobacter pylori infections | Europe EP3634444 | LactoSpore® + Saberry® | |
| Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof | Europe EP3544620 | LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement | Europe EP3253400 | Olepent® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Europe EP3558283 | Artocarpus hirsutus | |
| Use of piperine as a bioavailability enhancer | Europe EP0810868 | BioPerine® | |
| Bioprotectant composition, method of use and extraction process of curcuminoids | Europe EP0839037 | Curcumin C3 Complex® | |
| Forskolin for promoting lean body mass | Europe EP0977564 | ForsLean® | |
| Neuroprotective compositions and their use | Europe EP3638278 | Sabroxy® | |
| Enzyme composition for therapeutic management of muscle soreness | Europe EP3534934 | DigeZyme® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Europe EP3478304 | LactoSpore® | |
| Adaptogenic compositions and applications thereof | Europe EP3419640 | Polybos | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Europe EP3356545 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3291805 | Cyperus | |
| Coconut water and its method of preparation | Europe EP1341547 | Cococin | |
| Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells | Europe EP1328263 | Curcumin C3 Reduct® | |
| Bioavailable composition of natural and synthetic HCA | Europe EP1254209 | Garcitrin® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Europe EP3240553 | LactoSpore® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Europe EP1171144 | Curcumin C3 Reduct | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Europe EP1968620 | SelenoForce® | |
| Process for preparing water soluble diterpenes and their applications | Europe EP1718568 | Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Europe EP1791423 | Boswellin® | |
| Hepatoprotectant activity of garcinol | Europe EP2658374 | Livinol | |
| Protective compositions for dermal papilla cells | Europe EP2461786 | Saberry® + Cococin | |
| Method for the treatment of hypercholesterolemia | Europe EP2937084 | CurCousin® | |
| Calebin A for use in the treatment of inflammation and obesity | Europe EP2663185 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Europe EP2695603 | Saberry® + Cococin + Se Peptide | |
| Composition and method for the protection of articular cartilage | Europe EP2893926 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Europe EP2989197 | LactoSporin® | |
| Calebin A for inducing lipolysis | Europe EP3085370 | CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | Europe EP2963007 | CurCousin® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP2744571 | Cyperus | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3108935 | Cyperus | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Europe EP3185877 | LactoSpore® | |
| Process and composition for achieving mammalian energy balance | Europe EP3194575 | Forskolin | |
| Fructophilic lactic acid producing bacteria | Japan JP7469332 | Fructospore | |
| Liver protectant composition and therapeutic applications | Japan JP7411564 | LivLonga® | |
| Method and composition for therapeutic management of gluten intolerance | Japan JP7390398 | LactoSpore® + DigeZyme® | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | Japan JP7335360 | Hypertension Formulation | |
| Anti-pollution compositions containing Bacillus coagulans | Japan JP7262445 | LactoSpore® | |
| Spent turmeric - methods and compositions thereof | Japan JP7209691 | Starmeric® | |
| Hypolipidemic effects of Bacillus coagulans | Japan JP7220677 | LactoSpore® | |
| Adaptogenic compositions and applications thereof | Japan JP7220565 | Boswellin® PS + Saberry® / Cococin | |
| Composition and methods for beta secretase inhibition | Japan JP7209645 | Sabroxy® | |
| Modulation of immune function by Bacillus coagulans | Japan JP7183301 | Immunospore | |
| Hair care compositions containing extracellular metabolite preparation from bacillus coagulans | Japan JP7150753 | LactoSporin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Japan JP7135079 | LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Japan JP7089033 | Nigellin® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Japan JP7083215 | Arjuna | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | Japan JP7076148 | LactoSpore® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Japan JP7039626 | LactoSporin® | |
| Compositions for the management of hyperglycemia and related conditions | Japan JP7012857 | Nigellin® | |
| Compositions and methods for reducing flatulence | Japan JP6987888 | LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Japan JP6979518 | Oletrip | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Japan JP6938479 | LactoSpore® | |
| Use of Piperine as a bioavailability enhancer | Japan JP3953513 | BioPerine® | |
| Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Japan JP6920462 | Artocarpus hirsutus | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Japan JP6918988 | LactoSporin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Japan JP6908633 | LactoSpore® | |
| Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Japan JP6896885 | Artocarpus hirsutus | |
| Enzyme composition for therapeutic management of muscle soreness | Japan JP6857240 | DigeZyme® | |
| Composition containing Oroxylin A and method of extraction thereof | Japan JP6851476 | Sabroxy® | |
| Composition for management of Helicobacter pylori infection | Japan JP6839329 | LactoSpore® + Saberry® | |
| Neuroprotective compositions and their use | Japan JP6796217 | Sabroxy® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6759243 | Cyperus | |
| Process of obtaining compositions of stable Lutein and Lutein derivatives | Japan JP4227409 | Xenogard | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Japan JP4098985 | Cosmoperine® | |
| Bio-available compositions of natural and synthetic HCA | Japan JP4205943 | Garcitrin® | |
| Compositions and methods for the management of hyper-proliferative dermatological conditions | Japan JP4820819 | Boswellin® | |
| Process for preparing water soluble diterpenes and their applications | Japan JP5021305 | Ocufors® | |
| Hepatoprotectant activity of garcinol | Japan JP5980228 | Livinol | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Japan JP6064274 | Saberry® + Cococin + Se Peptide | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Japan JP6126307 | LactoSporin®, LactoSporin® + SabiLize® | |
| Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6135761 | Cyperus | |
| Composition and method for the protection of articular cartilage | Japan JP6142446 | CurCousin® | |
| Calebin A for hepatic steatosis | Japan JP6336943 | CurCousin® | |
| Oleanoyl peptide composition and a method of treating skin aging | Japan JP6176893 | Olepent® | |
| Method for the treatment of hypercholesterolemia | Japan JP6263707 | CurCousin® | |
| Anti-obesity potential of Calebin A | Japan JP6374716 | CurCousin® | |
| Process and compositions for achieving mammalian energy balance | Japan JP6472453 | Forskolin | |
| Synthesis of Calebin A and its biologically active analogs | Japan JP6490927 | CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Japan JP6584526 | Zingiber cassumnar | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Japan JP6629875 | LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Japan JP6630723 | LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX384468 | LactoSpore® | |
| Enzyme composition for its use in the therapeutic treatment of delayed onset muscular soreness | Mexico MX397674 | DigeZyme® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX389328 | Forskolin | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Mexico MX376004 | LactoSpore® | |
| Process for preparing water soluble diterpenes and their applications | Mexico MX260326 | Ocufors® | |
| Composition for down-regulating pro-inflammatory markers | Mexico MX328842 | Boswellin® PS | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Mexico MX355546 | Saberry® + Cococin +Se Peptide | |
| Enzyme composition for therapeutic management of muscle soreness | Malaysia MY-198090-A | DigeZyme® | |
| Adaptogenic compositions and applications thereof | Malaysia MY-189911-A | Polybos | |
| Process and compositions for achieving mammalian energy balance | Malaysia MY-188869-A | Forskolin | |
| Oleanoyl peptide composition and collagen enhancement | Malaysia MY-188723-A | Olepent® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Malaysia MY-185340-A | LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Malaysia MY-182658-A | LactoSpore® | |
| Calebin A for hepatic steatosis | Malaysia MY-182000-A | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Malaysia MY-181102-A | LactoSporin® | |
| Compositions and method for the protection of articular cartilage | Malaysia MY-175867-A | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Malaysia MY-168089-A | Saberry® + Cococin +Se Peptide | |
| Method for the treatment of hypercholesterolemia | Malaysia MY-170067-A | CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Malaysia MY-174855-A | LactoSpore® | |
| Hypolipidemic effects of Bacillus coagulans | New Zealand NZ760204 | LactoSpore® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | New Zealand NZ758787 | LactoSpore® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | New Zealand NZ760781 | Arjuna | |
| Compositions and methods for reducing flatulence | New Zealand NZ759306 | LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | New Zealand NZ732234 | LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | New Zealand NZ748360 | LactoSpore® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | New Zealand NZ748553 | LactoSpore® | |
| Composition containing Oroxylin A and method of extraction thereof | New Zealand NZ753943 | Sabroxy® | |
| Enzyme composition for therapeutic management of muscle soreness | New Zealand NZ752952 | DigeZyme® | |
| Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives | New Zealand NZ552997 | Forskolin | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | New Zealand NZ552027 | Boswellin® | |
| Commercial process for making forskolin and its derivatives | New Zealand NZ568652 | Ocufors® | |
| Process for preparing water soluble diterpenes and their applications | New Zealand NZ545765 | Ocufors® | |
| Bioavailable composition of natural and synthetic HCA | New Zealand NZ518116 | Garcitrin® | |
| Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | New Zealand NZ514884 | Curcumin C3 Reduct | |
| Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | New Zealand NZ568233 | SelenoForce® | |
| Protective compositions for dermal papilla cells | New Zealand NZ598630 | Saberry®+ Cococin | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | New Zealand NZ600307 | Saberry® + Cococin +Se dipeptide | |
| Method for the treatment of hypercholesterolemia | New Zealand NZ624269 | CurCousin® | |
| Hepatoprotectant activity of garcinol | New Zealand NZ609878 | Livinol | |
| Anti-obesity potential of Calebin A | New Zealand NZ614076 | CurCousin® | |
| Synthesis of Calebin A and its biologically active analogs | New Zealand NZ627247 | CurCousin® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | New Zealand NZ622927 | Cyperus | |
| Anti-obesity potential of calebin A | New Zealand NZ715053 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | New Zealand NZ711345 | LactoSporin®, LactoSporin® + SabiLize® | |
| Composition and method for the protection of articular cartilage | New Zealand NZ622909 | CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | New Zealand NZ735027 | Zingiber cassumnar | |
| Method to solubilize curcuminoids in water | New Zealand NZ734491 | UC3 clear | |
| Process and compositions for achieving mammalian energy balance | New Zealand NZ720422 | Forskolin | |
| Anti-pollution compositions containing Bacillus coagulans | Russia RU2745755 | LactoSpore® | |
| Process for the isolation of novel glycosides from Pterocarpus marsupium and their therapeutic effects | Russia RU2799555 | pTeroSol | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Russia RU2733372 | Oletrip | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Russia RU2366412 | Boswellin® | |
| Anti-obesity potential of Calebin A | Russia RU2543334 | CurCousin® | |
| Hepatoprotectant activity of garcinol | Russia RU2585245 | Livinol | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | Russia RU2606752 | Saberry® + Cococin + Se Peptide | |
| Calebin A for hepatic steatosis | Russia RU2643297 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Russia RU2617965 | LactoSporin®, LactoSporin® + SabiLize® | |
| Calebin A for osteoporosis | Russia RU2653103 | CurCousin® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Russia RU2694053 | Zingiber cassumnar | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Russia RU2691404 | Cyperus | |
| Enzyme composition for therapeutic management of muscle soreness | Singapore SG11201903791R | DigeZyme® | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Singapore SG11201707112P | Zingiber cassumnar | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Singapore SG11201809841Q | LactoSpore® | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Singapore SG11201706099Q | LactoSpore® | |
| Process and compositions for achieving mammalian energy balance | Singapore SG11201801873T | Forskolin | |
| Process for preparing water soluble diterpenes and their applications | Singapore SG121197 | Ocufors® | |
| Compositions and methods for the management of hyperproliferative dermatological conditions | Singapore SG136165 | Boswellin® | |
| Calebin A for hepatic steatosis | Singapore SG10201503805X | CurCousin® | |
| Composition and methods for the protection of articular cartilage | Singapore SG11201605336Y | CurCousin® | |
| Anti-obesity potential of calebin A | Singapore SG192695 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Singapore SG11201505628P | LactoSporin®, LactoSporin® + SabiLize® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Singapore SG11201700006U | LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Singapore SG11201707106U | Cyperus | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | South Africa ZA2022/00266 | Hypertension Formulation | |
| Fructophilic lactic acid producing bacteria | South Africa ZA2021/10214 | Fructospore | |
| Aphrodisiac composition and management of male sexual dysfunction | South Africa ZA2020/07819 | Withanalpha | |
| Compositions containing thymohydroquinone and their method of preparation | South Africa ZA2020/04531 | Nigellin® | |
| Liver protectant composition and therapeutic applications | South Africa ZA2020/06540 | LivLonga® | |
| Modulation of immune function by Bacillus coagulans | South Africa ZA2020/07348 | Immunospore | |
| Skin care compositions and their applications | South Africa ZA2020/06708 | Ethyl Ascorbic Acid + SabiWhite® | |
| Compositions for the management of hyperglycemia and related conditions | South Africa ZA2020/04532 | Nigellin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | South Africa ZA2019/00501 | LactoSpore® | |
| Enzyme composition for maintenance of metabolic health | South Africa 2019/07676 | DigeZyme® | |
| Composition and methods for the management of hyperproliferative dermatological Conditions | South Africa ZA2007/0694 | Boswellin® | |
| Process for preparing water soluble diterpenes and their applications | South Africa ZA2006/01898 | Ocufors® | |
| Anti-obesity potential of Calebin A | South Africa ZA2013/05918 | CurCousin® | |
| Method to solubilize curcuminoids in water | South Africa ZA2017/06503 | UC3 Clear | |
| Enzyme composition for therapeutic management of muscle soreness | South Africa ZA2019/02715 | DigeZyme® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Great Britain GB2380675 | Cosmoperine® | |
| Process for preparing water soluble diterpenes and their application | Uzbekistan 4028 | Ocufors® | |
| Method and composition for therapeutic management of gluten intolerance | Eurasia EA048069 | LactoSpore® | |
| Compositions for the management of hyperglycemia and related conditions | Eurasia EA047210 | Nigellin® | |
| Alcoholic beverage composition containing Bacillus coagulans | Eurasia EA045649 | LactoSpore® | |
| Compositions containing thymohydroquinone and their method of preparation | Eurasia EA045642 | Nigellin® | |
| Skin care compositions and their applications | Eurasia EA045810 | Ethyl Ascorbic Acid + SabiWhite® | |
| Liver protectant composition and therapeutic applications | Eurasia EA045555 | LivLonga® | |
| Enzyme composition for therapeutic management of muscle soreness | Eurasia EA044794 | DigeZyme® | |
| Aphrodisiac Composition And Management Of Male Sexual Dysfunction | Eurasia EA044487 | Withanalpha | |
| Process and composition for achieving mammalian energy balance | Eurasia EA38685 | Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Eurasia EA037312 | LactoSpore® | |
| Process for preparing water soluble diterpenes and their applications | Eurasia EA012836 | Ocufors® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Eurasia EA038255 | LactoSpore® | |
| Protective compositions for dermal papilla cells | Eurasia EA20368 | Saberry® + Cococin | |
| Use of a composition for down-regulating/inhibiting PGE2 | Eurasia EA023717 | Boswellin® PS | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Eurasia EA025578 | Cyperus | |
| Method for the treatment of hypercholesterolemia | Eurasia EA027148 | CurCousin® | |
| Use of calebin A to protect mammalian articular cartilage from pathological damage | Eurasia EA027614 | CurCousin® | |
| Synthesis of calebin A and its biologically active analogs | Eurasia EA027726 | CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Eurasia EA034017 | LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement | Eurasia EA03512 | Olepent® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Philippines PH1-2018-502419 | LactoSpore® | |
| Oleanoyl peptide composition and collagen enhancement | Philippines PH1-2017-501234 | Olepent® | |
| Adaptogenic compositions and applications thereof | Philippines PH1-2018-501607 | Boswellin® PS + Saberry® / Cococin | |
| Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Philippines PH1-2017-501663 | Zingiber cassumunar | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Philippines PH1-2017-50132 | LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Philippines PH1-2017-500059 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Philippines PH1-2015-500349 | Cyperus | |
| Process for preparing water soluble diterpenes and their applications | Philippines PH1-2006-500481 | Ocufors® | |
| Method for the treatment of hypercholesterolemia | Philippines PH1-2014-000244 | CurCousin® | |
| Calebin A for hepatic steatosis | Philippines PH1-2015-000188 | CurCousin® | |
| Composition and method for the protection of articular cartilage | Philippines PH1-2016-501138 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Philippines PH1-2015-502025 | LactoSporin®, LactoSporin® + SabiLize® | |
| Method and composition for therapeutic management of gluten intolerance | Republic of Korea KR10-2684843 | LactoSpore® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | Republic of Korea KR10-2648066 | LactoSpore® | |
| Compositions for the management of hyperglycemia and related conditions | Republic of Korea KR10-2577863 | Nigellin® | |
| Aphrodisiac composition and management of male sexual dysfunction | Republic of Korea KR10-2571381 | Withanalpha | |
| Modulation of immune function by Bacillus coagulans | Republic of Korea KR10-2558669 | Immunospore | |
| Compositions containing thymohydroquinone and their method of preparation | Republic of Korea KR10-2539298 | Nigellin® | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Republic of Korea KR10-2533865 | LactoSpore® | |
| Alcoholic beverage composition containing Bacillus coagulans | Republic of Korea KR10-2515209 | LactoSpore® | |
| Liver protectant compositions and therapeutic applications | Republic of Korea KR10-2498126 | LivLonga® | |
| Compositions and methods for reducing flatulence | Republic of Korea KR10-2452792 | LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Republic of Korea KR10-2412222 | Oletrip | |
| Compositions for management of Helicobacter pylori infections | Republic of Korea KR10-2403453 | LactoSpore® + Saberry® | |
| Anti-pollution compositions containing Bacillus coagulans | Republic of Korea KR10-2376076 | LactoSpore® | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | Republic of Korea KR10-2296051 | LactoSporin® | |
| Anti-obesity potential of garcinol | Republic of Korea KR10-2289324 | Garcinol | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Republic of Korea KR10-2288904 | LactoSporin® | |
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | Republic of Korea KR10-2288897 | LactoSporin® | |
| Process and compositions for achieving mammalian energy balance | Republic of Korea KR10-2169620 | Forskolin | |
| Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Republic of Korea KR10-2157043 | LactoSpore® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1600212 | Cyperus | |
| Synthesis of Calebin A and its biologically active analogs | Republic of Korea KR10-1629561 | CurCousin® | |
| Method for the treatment of hypercholesterolemia | Republic of Korea KR10-1647549 | CurCousin® | |
| Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685263 | CurCousin® | |
| Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685333 | CurCousin® | |
| Anti-obesity potential of Calebin A | Republic of Korea KR10-1702702 | CurCousin® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1717889 | Cyperus | |
| Calebin A for hepatic steatosis | Republic of Korea KR10-1763474 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Republic of Korea KR 10-1770902 | LactoSporin®, LactoSporin® + SabiLize® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Republic of Korea KR10-2089566 | LactoSpore® | |
| Aphrodisiac composition and management of male sexual dysfunction | Indonesia IDP000093473 | WithanAlpha&trade | |
| Adaptogenic compositions and applications thereof | Indonesia IDP000088019 | Boswellin® PS + Saberry® / Cococin | |
| Enzyme composition for therapeutic management of muscle soreness | Indonesia IDP000089633 | DigeZyme® | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Indonesia IDP000085113 | Arjuna | |
| Oleanoyl peptide composition and collagen enhancement | Indonesia IDP000074771 | Olepent® | |
| Novel pcr primers and methods thereof for the identification of Bacillus coagulans | Indonesia IDP000074645 | LactoSpore® | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000074062 | Cyperus | |
| Process and compositions for achieving mammalian energy balance | Indonesia IDP000071226 | ForsLean® | |
| Calebin A for hepatic steatosis | Indonesia IDP000067993 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cell | Indonesia IDP000051688 | Saberry® + Cococin + Se-dipeptide | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Indonesia IDP00201506134 | LactoSporin®, LactoSporin® + SabiLize® | |
| Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000062703 | Cyperus | |
| Calebin A and its effect on hypercholesterolemia | Indonesia IDP000064827 | CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Indonesia IDP000066793 | LactoSpore® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | United Arab Emirates AE6288 | LactoSpore® | |
| Compositions and methods for the management of hyperproliferative dermatological condition | United Arab Emirates AE3178 | Boswellin® | |
| Compositions for Management of Polycystic Ovary Syndrome | US 12,233,032 | Curcumin BD3 Complex | |
| Compositions for management of acute nephrotoxicity | US 12,053,500 | Curucmin BD3 Complex | |
| Method of isolating secondary metabolites from cambium derived callus cultures | US 12,022,786 | Callus culture | |
| Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition | US 11,957,728 | Curcumin BD3 Complex | |
| Process and compositions for enhancing energy expenditure | US 11,925,671 | Cirpusins® | |
| Compositions for managing chronic obstructive pulmonary disease | US 11,925,606 | Curcumin BD3 Complex | |
| Skin care applications of extracellular metabolites from Bacillus coagulans | US 11,865,203 | LactoSporin® | |
| Therapeutic compositions and methods for pulmonary fibrosis | US 11,744,807 | Isogarcinol + Octohydrocurcumin | |
| Curcuminoid composition for therapeutic management of metabolic syndrome | US 11,707,438 | C3 Reduct® Special | |
| Curcuminoid composition and its therapuetic potential in managing lung fibrosis | US 11,491,119 | C3 Reduct® Special | |
| Compositions and methods for beta secretase inhibition | US 11,458,117 | Sabroxy® | |
| Method and composition for therapeutic management of gluten intolerance | US 11,419,906 | LactoSpore® | |
| Compositions and methods for management of atrophic gastritis and colitis | US 11,413,318 | LactoSpore® | |
| Plant actives and their anti-pollution effects thereof | US 11,351,102 | Sabroxy® + (THC / Pterostilbene / Resvenox) | |
| Alcoholic beverage composition containing Bacillus coagulans | US 11,332,702 | LactoSpore® | |
| Microbial bioconversion of curcuminoids to Calebin-A | US 11,299,706 | CurCousin® | |
| Isolates from spent turmeric for the management of rheumatoid arthritis | US 11,298,395 | Starmeric® | |
| Modulation of immune function by Bacillus coagulans | US 11,298,381 | Immunospore | |
| Hypolipidemic effects of Bacillus coagulans | US 11,213,553 | LactoSpore® | |
| Stable probiotic composition for the management of lactose intolerance | US 11,202,810 | LactoSpore® | |
| Fructophilic lactic acid producing bacteria | US 11,197,898 | Fructospore | |
| Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | US 11,123,382 | LactoSporin® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | US 11,052,125 | LactoSpore® | |
| Compositions for weight loss | US 11,052,125 | Cyperus + Forskolin + Garcinol | |
| Composition for the therapeutic management of hypomelanotic skin conditions | US 11,045,517 | Forskolin + Nigellin® | |
| Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | US 10,966,919 | LactoSporin® | |
| Bioactive molecules from Oroxylum indicum and their therapeutic applications | US 10,959,980 | Sabroxy® | |
| Compositions containing thymohydroquinone and their method of preparation | US 10,945,969 | Nigellin® | |
| Method of inhibiting propionibacterium acnes | US 10,898,536 | Artocarpus | |
| Neuroprotective compositions and their use | US 10,894,029 | Sabroxy® | |
| Compositions for the management of hyperglycemia and related conditions | US 10,881,623 | Nigellin® | |
| Composition for prostaglandin transporter inhibition and related therapeutic applications | US 10,864,243 | Sabeet® + Nigellin® + Arjuna + SelenoForce® | |
| Aphrodisiac composition and management of male sexual dysfunction | US 10,864,242 | Xxtrastrong | |
| Skin care compositions and their applications | US 10,864,154 | Ethyl ascorbic acid + THC | |
| Compositions and methods for reducing flatulence | US 10,806,760 | LactoSpore® | |
| Composition for management of Helicobacter pylori infection | US 10,792,295 | LactoSpore® + Saberry® | |
| Adaptogenic compositions and applications thereof | US 10,716,823 | Polybos + Saberry® Polybos + Cococin | |
| Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof | US 10,668,115 | LactoSpore® | |
| Liver protectant compositions and therapeutic applications | US 10,653,643 | LivLonga® | |
| Beverage compositions containing Bacillus coagulans MTCC 5856 | US 10,609,935 | LactoSpore® | |
| Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | US 10,588,844 | Oletrip | |
| Composition containing Oroxylin A and method of extraction thereof | US 10,555,982 | Oroxylin | |
| Telomerase enhancement potential of Ecdysterone | US 10,548,902 | Ecdysterone | |
| Functional nutritional blend for thermo-metabolic performance | US 10,477,886 | Metabolicgard | |
| Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | US 10,479,749 | Arjunoglucoside | |
| Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | US 10,421,734 | 3-Amino Tetrahydrofurans | |
| Process for synthesis of Oroxylin A | US 10,407,401 | Sabroxy® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10,323,227 | LactoSpore® + Starmeric® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10,293,008 | LactoSpore® | |
| Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | US 10,260,112 | LactoSpore® | |
| Functional nutritional blend for thermo-metabolic performance | US 10,258,073 | Metabolicgard | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 10,172,903 | Cyperus | |
| Bacillus coagulans MTCC 5856 for the management of major depressive disorder | US 10,166,261 | LactoSpore® | |
| Process and compositions for achieving mammalian energy balance | US 10,085,963 | Forskolin | |
| Oleanoyl peptide composition and skin hydration | US 10,071,043 | Olepent® | |
| Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,913,809 | Zingiber cassumnar | |
| Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,833,422 | Zingiber cassumnar | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,782,450 | Cyperus | |
| Calebin A for hepatic steatosis | US 9,737,502 | CurCousin® | |
| Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 9,717,766 | LactoSpore® + LactoCran® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | US 9,681,666 | LactoSporin® + SabiLize® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | US 9,681,665 | LactoSporin® | |
| Method for the treatment of hypercholesterolemia | US 9,668,999 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | US 9,635,862 | LactoSporin®, LactoSporin® + SabiLize® | |
| Method for the treatment of hypercholesterolemia | US 9,610,273 | CurCousin® | |
| Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | US 9,596,861 | LactoSporin® | |
| Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans | US 9,579,352 | LactoSpore® | |
| Calebin A for osteoporosis | US 9,539,232 | CurCousin® | |
| Synergistic selenopeptide formulations for the protection of dermal papilla cells | US 9,498,423 | Saberry® + Cococin + Se Peptide | |
| Process for the manufacture of 3′-hydroxy pterostilbene | US 9,458,075 | 3-hydroxypterostilbene | |
| Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,387,193 | Cyperus | |
| Synthesis of Calebin A and its biologically active analogs | US 9,365,486 | CurCousin® | |
| Anti-obesity potential of Calebin A | US 9,328,330 | CurCousin® | |
| Composition and method for the protection of articular cartilage | US 9,220,703 | CurCousin® | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,056,074 | 3-hydroxypterostilbene | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,050,284 | 3-hydroxypterostilbene | |
| Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 9,029,547 | Pharmaceutical Intermediates | |
| Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,029,424 | 3-hydroxypterostilbene | |
| Oleanoyl peptide composition and method of treating skin aging | US 8,987,212 | Olepent® | |
| Anti-obesity potential of Calebin A | US 8,933,121 | CurCousin® | |
| Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 8,853,407 | Pharmaceutical intermediates | |
| Inotilone derivatives as coherent biological response modifier (cBMR) | US 8,394,852 | Inotilone derivatives | |
| Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals | US 8,383,594 | Olepent® | |
| Compositions and its use in treating obesity or inducing weight loss | US 8,329,743 | Livinol+ Pterostilbene + Anthocyanin | |
| Preservative system for cosmetic formulations—compositions and methods thereof | US 8,329,095 | SabiLize® | |
| Protective compositions for dermal papilla cells | US 8,247,003 | Saberry® + Cococin | |
| Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis, pharmaceutical and cosmeceutical applications thereof | US 8,193,156 | LSM-Dipeptide Synthetic route | |
| Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione | US 8,119,696 | Tetrapure® | |
| Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis | US 8,003,614 | MSC-Dipeptide Synthetic route | |
| Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof | US 7,842,842 | Woody Odorants | |
| Composition and methods for the management of hyperproliferative dermatological conditions | US 7,582,314 | Boswellin® | |
| Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis | US 7,521,580 | Curcuminoid analogs | |
| Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives | US 7,514,573 | 3-Aminotetrahydrofurans | |
| Convenient process of manufacture for Difluoromethylornithine and related compounds | US 7,345,196 | Efflornithine | |
| Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance | US 7,300,682 | Cococin | |
| Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers | US 7,253,324 | Stilbenes | |
| Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails | US 7,217,546 | Policosanol | |
| Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses | US 7,202,270 | Liposol | |
| Bioavailable composition of natural and synthetic HCA | US 7,063,861 | Garcitrin® | |
| Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | US 7,014,874 | SelenoForce® | |
| Convenient process of manufacture for Difluoromethylornithine and related compounds | US 6,998,502 | Efflornithine | |
| Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use | US 6,982,273 | Methyselene (MSC) | |
| Process for preparing water soluble diterpenes and their applications | US 6,960,300 | Ocufors® | |
| Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | US 6,849,645 | Cosmoperine® (THP) | |
| Manufacturing processes for Se-methyl-selenocysteine | US 6,794,537 | Methyselene (MSC) | |
| Process of obtaining compositions of stable lutein and lutein derivatives | US 6,689,400 | ZeaLutein | |
| Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii | US 6,607,712 | Coleus Oil | |
| Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease | US 6,436,991 | Gugulipid® | |
| New Chemical entities with multiple modes of anti-inflammatory action | US 7,378,442 | AKBBA+NSAIDS | |
| New chemical entities with multiple modes of anti-inflammatory action | US 7,371,889 | AKBBA+NSAIDS | |
| Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels | US 7,160,562 | Metformin-like compounds | |
| Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid | US 6,770,782 | Citrin® K | |
| Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays | US 6,653,327 | Tetrahydrocurcuminoids | |
| Process for making high purity piperine for nutritional use | US 6,054,585 | BioPerine® | |
| Use of piperine as a bioavailability enhancer | US 5,972,382 | BioPerine® | |
| Bioprotectant composition, method of use and extraction process of curcuminoids | US 5,861,415 | Curcumin C3 Complex® | |
| Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders | US 5,804,596 | ForsLean® | |
| Potassium hydroxycitrate for the suppression of appetite and induction of weight loss | US 5,783,603 | Citrin® K | |
| Use of piperine as a bioavailability enhancer | US 5,744,161 | BioPerine® | |
| Use of piperine to increase bioavailability of nutritional compounds | US 5,536,506 | BioPerine® |